Hillstream BioPharma, Inc. Profile Avatar - Palmy Investing

Hillstream BioPharma, Inc.

Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) for the treatment resistant cancers. The company's produc…

Biotechnology
US, Bridgewater [HQ]

News

Theses · Events · Sentiments
End of HILS's Analysis
CIK: 1861657 CUSIP: 432705101 ISIN: US4327051011 LEI: - UEI: -
Secondary Listings
HILS has no secondary listings inside our databases.